DURECT CORP Contracts & Agreements

101 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Asset purchase agreement by and between the Company and ALZET, LLC dated as of November 22, 2024
Purchase Agreements
DURECT CORP
Pharmaceuticals
2025
Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015
License Agreements
DURECT CORP
Pharmaceuticals
2024
Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018
License Agreements
DURECT CORP
Pharmaceuticals
2024
DURECT Corporation 2000 Stock Plan, as amended
Stock Agreements
DURECT CORP
Pharmaceuticals
2024
Form of Employee Restricted Stock Unit Award Agreement for use with the DURECT Corporation 2000 Stock Plan
Stock Agreements
DURECT CORP
Pharmaceuticals
CA
2024
Description of Securities of the Registrant Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
DURECT CORP
Pharmaceuticals
DE
2024
Sixth amendment to Lease between the Company and De Anza Enterprises LLC dated as of September 6, 2023
Lease Agreements
DURECT CORP
Pharmaceuticals
2023
Addendum IV to Lease between the Company and Wescove Vacaville, LLC dated as of May 11, 2023
Lease Agreements
DURECT CORP
Pharmaceuticals
2023
Form of Warrant (July 2023)
Warrant Agreements
DURECT CORP
Pharmaceuticals
2023
Form of Securities Purchase Agreement, dated July 19, 2023
Purchase Agreements
DURECT CORP
Pharmaceuticals
NY
2023
DURECT Corporation 2000 Employee Stock Purchase Plan, as amended
Stock Agreements
DURECT CORP
Pharmaceuticals
DE
2023
Form of Warrant (February 2023)
Warrant Agreements
DURECT CORP
Pharmaceuticals
NY
2023
Form of Pre-Funded Warrant (February 2023)
Warrant Agreements
DURECT CORP
Pharmaceuticals
NY
2023
Form of Securities Purchase Agreement, dated February 3, 2023
Purchase Agreements
DURECT CORP
Pharmaceuticals
NY
2023
First Amendment to License Agreement by and between the Company and Innocoll Pharmaceuticals Limited dated September 19, 2022
License Agreements
DURECT CORP
Pharmaceuticals
2022
Offer letter between Timothy M. Papp and DURECT Corporation
DURECT CORP
Pharmaceuticals
2022
DURECT Corporation 2000 Stock Plan, as amended
Stock Agreements
DURECT CORP
Pharmaceuticals
2022
Fourth Amendment to Loan and Security Agreement between the Company and Oxford Finance LLC dated March 3, 2021
Loan Agreements
DURECT CORP
Pharmaceuticals
2022
License agreement by and between the Company and Innocoll Pharmaceuticals Limited dated December 21, 2021
License Agreements
DURECT CORP
Pharmaceuticals
CA
2022
Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015
License Agreements
DURECT CORP
Pharmaceuticals
2021
Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018
License Agreements
DURECT CORP
Pharmaceuticals
2021
Fifth Amendment to Loan and Security Agreement, dated May 28, 2021, by and between DURECT Corporation and Oxford Finance, LLC
Loan Agreements
DURECT CORP
Pharmaceuticals
2021
Asset purchase agreement between the Company and Evonik Corporation dated December 4, 2020
Purchase Agreements
DURECT CORP
Pharmaceuticals
2021
Executive Change of Control Policy, as amended December 9, 2020
Change of Control Agreements
DURECT CORP
Pharmaceuticals
2021
Underwriting Agreement, dated February 3, 2021, by and between DURECT Corporation and Cantor Fitzgerald & Co
Underwriting Agreements
DURECT CORP
Pharmaceuticals
NY
2021
Offer letter between Norman L. Sussman and DURECT Corporation dated October 12, 2020
DURECT CORP
Pharmaceuticals
2020
DURECT Corporation 2000 Employee Stock Purchase Plan, as amended
Stock Agreements
DURECT CORP
Pharmaceuticals
DE
2020
Description of Securities of the Registrant
DURECT CORP
Pharmaceuticals
2020
2000 Stock Plan, as amended
Stock Agreements
DURECT CORP
Pharmaceuticals
2020
Third Amendment to Loan and Security Agreement, dated December 31, 2019, by and between DURECT Corporation and Oxford Finance, LLC
Loan Agreements
DURECT CORP
Pharmaceuticals
2020
License Agreement between the Company and Gilead Sciences, Inc. dated July 19, 2019
License Agreements
DURECT CORP
Pharmaceuticals
DE
2019
Form of Securities Purchase Agreement
Purchase Agreements
DURECT CORP
Pharmaceuticals
NY
2019
DURECT Corporation 2000 Stock Plan, as amended
Stock Agreements
DURECT CORP
Pharmaceuticals
2019
Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated December 5, 2012
License Agreements
DURECT CORP
Pharmaceuticals
2018
Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015
License Agreements
DURECT CORP
Pharmaceuticals
2018
Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018
License Agreements
DURECT CORP
Pharmaceuticals
2018
Second Amendment to Loan and Security Agreement between the Company and Oxford Finance LLC dated November 1, 2018
Loan Agreements
DURECT CORP
Pharmaceuticals
2018
Third Amendment to Lease between Bubb Road Joint Venture LLC, as successor to Renault & Handley Employees Investment Co. and the Company dated as of September 17, 2018
Joint Venture Agreements
DURECT CORP
Pharmaceuticals
2018
Fifth Amendment to Lease between De Anza Enterprises and the Company dated as of August 15, 2018
Lease Agreements
DURECT CORP
Pharmaceuticals
2018
Addendum III to Lease between the Company and Northwest Asset Management Company dated as of April 10, 2018
Lease Agreements
DURECT CORP
Pharmaceuticals
2018
First Amendment to the Development and Commercialization Agreement between the Company and SANDOZ AG effective as of May 4, 2018
Development Agreements
DURECT CORP
Pharmaceuticals
2018
DURECT Corporation 2000 Stock Plan, as amended
Stock Agreements
DURECT CORP
Pharmaceuticals
2018
First Amendment to Loan and Security Agreement between the Company and Oxford Finance LLC dated February 28, 2018
Loan Agreements
DURECT CORP
Pharmaceuticals
2018
Patent purchase agreement between the Company and Indivior UK Limited dated as of September 26, 2017
Purchase Agreements
DURECT CORP
Pharmaceuticals
2017
DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between DURECT CORPORATION and SANDOZ AG dated May 5, 2017
Development Agreements
DURECT CORP
Pharmaceuticals
CA
2017
DURECT CORPORATION 2000 EMPLOYEE STOCK PURCHASE PLAN (as last amended June19, 2017)
Stock Agreements
DURECT CORP
Pharmaceuticals
DE
2017
LOAN AND SECURITY AGREEMENT
Loan Agreements
DURECT CORP
Pharmaceuticals
CA
2016
DURECT CORPORATION 2000 STOCK PLAN (asamended on March 13, 2000) (as further amended on March 31, 2000) (as further amended on March 15, 2001) (as further amended April 14, 2005)...
Stock Agreements
DURECT CORP
Pharmaceuticals
2016
DURECTCORPORATION 12,000,000 Shares Common Stock ($0.0001par value) Underwriting Agreement
Underwriting Agreements
DURECT CORP
Pharmaceuticals
NY
2016
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT AND FIRST AMENDMENT TODISBURSEMENT LETTER
Loan Agreements
DURECT CORP
Pharmaceuticals
2015
DURECT CORPORATION 2000 EMPLOYEE STOCK PURCHASE PLAN (as last amended June 15, 2015)
Stock Agreements
DURECT CORP
Pharmaceuticals
DE
2015
LICENSEAGREEMENT by and between Durect Corporation and Santen Pharmaceutical Co., Ltd. Dated December 11, 2014
DURECT CORP
Pharmaceuticals
DE
2015
EXCLUSIVELICENSE AGREEMENT
DURECT CORP
Pharmaceuticals
2015
LOAN AND SECURITY AGREEMENT
Loan Agreements
DURECT CORP
Pharmaceuticals
CA
2014
DURECT CORPORATION 2000 STOCK PLAN (as amended on March 13, 2000) (as further amended on March 31, 2000) (as further amended onMarch 15, 2001) (as further amended April 14, 2005)...
Stock Agreements
DURECT CORP
Pharmaceuticals
2014
ASSETTRANSFER AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
NY
2014
SECOND AMENDMENT TO LEASE
Lease Agreements
DURECT CORP
Pharmaceuticals
2014
DURECT CORPORATION EXECUTIVE CHANGE OF CONTROL POLICY
Change of Control Agreements
DURECT CORP
Pharmaceuticals
2014
DURECTCORPORATION 7,142,858 Shares Common Stock ($0.0001par value) Underwriting Agreement
Underwriting Agreements
DURECT CORP
Pharmaceuticals
NY
2013
FOURTH AMENDMENT TO LEASE
Lease Agreements
DURECT CORP
Pharmaceuticals
2013
ADDENDUM II TO STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE - GROSS
Lease Agreements
DURECT CORP
Pharmaceuticals
2013
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
CA
2013
AMENDMENT NO. 1 TO DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
2013
DURECT CORPORATION 14,000,000 Shares Common Stock ($0.0001 par value) Underwriting Agreement
Underwriting Agreements
DURECT CORP
Pharmaceuticals
NY
2012
LEASE TERMINATION AGREEMENT
Lease Agreements
DURECT CORP
Pharmaceuticals
2012
Re: Amendment to Commercial Real Estate Lease
Lease Agreements
DURECT CORP
Pharmaceuticals
2012
DEVELOPMENT AND LICENSE AGREEMENT BETWEEN DURECT CORPORATION AND ZOGENIX, INC. DATED AS OF JULY 11, 2011
License Agreements
DURECT CORP
Pharmaceuticals
CA
2011
DURECT CORPORATION 2000 STOCK PLAN (as amended on March 13, 2000) (as further amended on March 31, 2000) (as further amended onMarch 15, 2001) (as further amended April 14, 2005)...
Stock Agreements
DURECT CORP
Pharmaceuticals
2011
AMENDMENT NO. 2 TODEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
2011
DURECT CORPORATION AT 2200 RIVERCHASE LEASE AGREEMENT 1 TABLE OF CONTENTS
Lease Agreements
DURECT CORP
Pharmaceuticals
2011
THIRD AMENDMENT TO LEASE
Lease Agreements
DURECT CORP
Pharmaceuticals
2011
EXCIPIENT MANUFACTURING AND SUPPLY AGREEMENT
Supply Agreements
DURECT CORP
Pharmaceuticals
NY
2009
SECOND AMENDMENT TO LEASE
Lease Agreements
DURECT CORP
Pharmaceuticals
2009
FIRST LEASE EXTENSION
Lease Agreements
DURECT CORP
Pharmaceuticals
2009
Re: Amendment to Commercial Real Estate Lease
Lease Agreements
DURECT CORP
Pharmaceuticals
2009
AMENDMENT NO. 1 TO LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
2008
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
NY
2008
DURECT CORPORATION EXECUTIVE CHANGE OF CONTROL POLICY
Change of Control Agreements
DURECT CORP
Pharmaceuticals
2008
AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL
DURECT CORP
Pharmaceuticals
2008
AMENDMENT NO. 1 TO FEASIBILITY, DEVELOPMENT AND COMMERCIALIZATIONAGREEMENT
Development Agreements
DURECT CORP
Pharmaceuticals
2007
LEASE AGREEMENT
Lease Agreements
DURECT CORP
Pharmaceuticals
2007
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
2007
BETWEEN
DURECT CORP
Pharmaceuticals
DE
2007
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
CA
2006
SUCROSE ACETATE ISOBUTYRATE PHARMACEUTICAL GRADE
DURECT CORP
Pharmaceuticals
2006
7,400,000 Shares
DURECT CORP
Pharmaceuticals
NY
2005
THIRD ADDENDUM TO STANDARDINDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE - NET
Lease Agreements
DURECT CORP
Pharmaceuticals
2005
CUPERTINO,CALIFORNIA LEASE FOR 2 RESULTS WAY
Lease Agreements
DURECT CORP
Pharmaceuticals
CA
2005
LEASE AGREEMENT
Lease Agreements
DURECT CORP
Pharmaceuticals
2005
LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
NY
2005
COMMERCIALREAL ESTATE LEASE
Lease Agreements
DURECT CORP
Pharmaceuticals
2004
LEASE AGREEMENT
Lease Agreements
DURECT CORP
Pharmaceuticals
2004
LICENSE AND COMMERCIALIZATION AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
CA
2004
EXHIBIT A Master Lease EXHIBIT B Space Plan Showing Tenant Improvements EXHIBIT C Initial Alterations Requirements
Lease Agreements
DURECT CORP
Pharmaceuticals
2004
Re: Amendment to Development, Commercialization and Supply License Agreement
License Agreements
DURECT CORP
Pharmaceuticals
2004
By and between DURECT CORPORATION and
DURECT CORP
Pharmaceuticals
NY
2003
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
DURECT CORP
Pharmaceuticals
NY
2003
$50,000,000
DURECT CORP
Pharmaceuticals
DE
2003
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
NY
2003
DEVELOPMENT, COMMERCIALIZATION AND SUPPLY LICENSE AGREEMENT BETWEEN DURECTCORPORATION AND
License Agreements
DURECT CORP
Pharmaceuticals
DE
2003
DEVELOPMENT AND LICENSE AGREEMENT
License Agreements
DURECT CORP
Pharmaceuticals
CA
2003